PortfoliosLab logoPortfoliosLab logo
IONS vs. WVE
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

IONS vs. WVE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Ionis Pharmaceuticals, Inc. (IONS) and Wave Life Sciences Ltd. (WVE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IONS achieves a -34.56% return, which is significantly higher than WVE's -67.59% return. Over the past 10 years, IONS has outperformed WVE with an annualized return of 3.21%, while WVE has yielded a comparatively lower -11.28% annualized return.


IONS

1D
-2.83%
1M
-36.71%
6M
-37.38%
YTD
-34.56%
1Y
20.31%
3Y*
7.90%
5Y*
6.87%
10Y*
3.21%
ALL TIME*
5.06%

WVE

1D
-4.34%
1M
-11.98%
6M
-57.42%
YTD
-67.59%
1Y
-36.15%
3Y*
8.03%
5Y*
0.00%
10Y*
-11.28%
ALL TIME*
-10.00%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$189.49M$272.86M$184.93M
$12.78M$14.44M$20.78M

IONS vs. WVE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
IONS
Ionis Pharmaceuticals, Inc.
-34.56%126.29%-30.90%33.94%24.12%-46.18%-6.41%11.75%7.48%5.16%
WVE
Wave Life Sciences Ltd.
-67.59%37.43%144.95%-27.86%122.93%-60.10%-1.81%-80.93%19.77%34.23%

Correlation

The correlation between IONS and WVE is 0.35, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.35

Correlation (3Y)
Balances recent behavior with more history.

0.33

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.30

Correlation (10Y)
Provides a long-term view across more market conditions.

0.28

Correlation (All Time)
Calculated using the full available price history since Nov 11, 2015

0.26

Fundamentals

Market Cap

IONS:

$8.60B

WVE:

$1.06B

EPS

IONS:

-$3.46

WVE:

-$1.08

PS Ratio

IONS:

9.67

WVE:

15.81

PB Ratio

IONS:

19.47

WVE:

2.46

Total Revenue (TTM)

IONS:

$873.76M

WVE:

$65.37M

Gross Profit (TTM)

IONS:

$857.70M

WVE:

$22.59M

EBITDA (TTM)

IONS:

$4.33B

WVE:

-$200.12M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IONS vs. WVE — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

IONS
IONS Risk / Return Rank: 6060
Overall Rank
IONS Sharpe Ratio Rank: 5959
Sharpe Ratio Rank
IONS Sortino Ratio Rank: 5858
Sortino Ratio Rank
IONS Omega Ratio Rank: 6464
Omega Ratio Rank
IONS Calmar Ratio Rank: 5858
Calmar Ratio Rank
IONS Martin Ratio Rank: 6262
Martin Ratio Rank

WVE
WVE Risk / Return Rank: 4242
Overall Rank
WVE Sharpe Ratio Rank: 3636
Sharpe Ratio Rank
WVE Sortino Ratio Rank: 5555
Sortino Ratio Rank
WVE Omega Ratio Rank: 5959
Omega Ratio Rank
WVE Calmar Ratio Rank: 2929
Calmar Ratio Rank
WVE Martin Ratio Rank: 3131
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

IONS vs. WVE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Ionis Pharmaceuticals, Inc. (IONS) and Wave Life Sciences Ltd. (WVE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


IONSWVEDifference
Sharpe ratioReturn per unit of total volatility

+0.58

Sortino ratioReturn per unit of downside risk

+0.14

Omega ratioGain probability vs. loss probability

1.16

1.13

+0.03

Calmar ratioReturn relative to maximum drawdown

0.51

-0.43

+0.94

Martin ratioReturn relative to average drawdown

1.64

-0.68

+2.31

IONS vs. WVE - Sharpe Ratio Comparison

The current IONS Sharpe Ratio is 0.39, which is higher than the WVE Sharpe Ratio of -0.19. The chart below compares the historical Sharpe Ratios of IONS and WVE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

IONS vs. WVE - Drawdown Comparison

The maximum IONS drawdown since its inception was -91.42%, smaller than the maximum WVE drawdown of -97.77%. Use the drawdown chart below to compare losses from any high point for IONS and WVE.


Loading charts...

Drawdown Indicators


IONSWVEDifference

Max Drawdown

Largest peak-to-trough decline

-91.42%

-97.77%

+6.35%

Max Drawdown (1Y)

Largest decline over 1 year

-40.15%

-74.14%

+33.99%

Max Drawdown (3Y)

Largest decline over 3 years

-52.36%

-74.14%

+21.78%

Max Drawdown (5Y)

Largest decline over 5 years

-52.36%

-81.08%

+28.72%

Max Drawdown (10Y)

Largest decline over 10 years

-70.39%

-97.77%

+27.38%

Current Drawdown

Current decline from peak

-40.15%

-90.02%

+49.87%

Average Drawdown

Average peak-to-trough decline

-52.26%

-65.12%

+12.86%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.53%

47.26%

-34.73%

Volatility

IONS vs. WVE - Volatility Comparison

Ionis Pharmaceuticals, Inc. (IONS) has a higher volatility of 29.82% compared to Wave Life Sciences Ltd. (WVE) at 12.84%. This indicates that IONS's price experiences larger fluctuations and is considered to be riskier than WVE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IONSWVEDifference

Volatility (1M)

Calculated over the trailing 1-month period

29.82%

12.84%

+16.98%

Volatility (6M)

Calculated over the trailing 6-month period

35.47%

77.83%

-42.36%

Volatility (1Y)

Calculated over the trailing 1-year period

52.79%

168.16%

-115.37%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

43.75%

114.49%

-70.74%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

45.64%

98.68%

-53.04%

Dividends

IONS vs. WVE - Dividend Comparison

Neither IONS nor WVE has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

IONS vs. WVE - Financials Comparison

This section allows you to compare key financial metrics between Ionis Pharmaceuticals, Inc. and Wave Life Sciences Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


IONS and WVE have a correlation of 0.35, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IONS has higher volatility (29.82%) compared to WVE (12.84%). In terms of maximum drawdown, IONS dropped -91.42% vs WVE's -97.77%.

IONS currently has the higher Sharpe Ratio (0.39 vs -0.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IONS and WVE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer